Acorah Software Products - Accounts Production16.4.675falsetrue31 December 20231 January 2023falsetrueNo description of principal activity1 January 202431 December 202431 December 202413091781Mr Yu-Ling MAiso4217:GBPiso4217:EURiso4217:USDxbrli:sharesxbrli:purexbrli:pure130917812023-12-31130917812024-12-31130917812024-01-012024-12-3113091781frs-bus:PrivateLimitedCompanyLtd2024-01-012024-12-3113091781frs-bus:FilletedAccounts2024-01-012024-12-3113091781frs-bus:Micro-entities2024-01-012024-12-3113091781frs-bus:AuditExempt-NoAccountantsReport2024-01-012024-12-3113091781frs-bus:Director12024-01-012024-12-31130917812022-12-31130917812023-12-31130917812023-01-012023-12-31
Registered number: 13091781
Oxford Chinese Medicine Research Centre Limited
Unaudited Financial Statements
For The Year Ended 31 December 2024
Silverstone Business Consulting Ltd
Salisbury House
29 Finsbury Circus
London
United Kingdom
EC2M 5SQ
Oxford Chinese Medicine Research Centre Limited
Balance Sheet
As At 31 December 2024
Balance Sheet
Registered number: 13091781
2024
2023
£
£
Current assets
1
1
NET CURRENT ASSETS
1
1
TOTAL ASSETS LESS CURRENT LIABILITIES
1
1
NET ASSETS
1
1
CAPITAL AND RESERVES
1
1
Notes
1.General Information
Oxford Chinese Medicine Research Centre Limited is a private company, limited by shares, incorporated in England & Wales, registered number 13091781. The registered office is Suite G04 1 Quality Court, Chancery Lane, London, England, WC2A 1HR.
2.Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2023: 1)
11
For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.